Interesting speculation by CITI on AMRN today:
Post# of 72447
(Total Views: 398)
Posted On: 09/24/2018 1:53:47 PM
Interesting speculation by CITI on AMRN today:
Citi sees another 5x upside in Amarin
Sep. 24, 2018 11:53 AM ET|By: Stephen Alpher, SA News Editor
Amarin (NASDAQ:AMRN) has skyrocketed more than 200% to $10.15 today after its fish oil capsule showed big benefits in a trial of more than 8K patients with elevated risk of heart issues.
Assuming the expanded REDUCE-IT label is granted, Citi sees peak sales of a whopping $2.7B. That assumes only about 2M of the 50B-70B eligible patients are treated. The team there sees upside to $50 per share, with Amarin being a strong acquisition target. Source: Notable Calls
Also on the move on the news is Acasti Pharma (ACST +26.9%), whose heart pill candidate CaPre is mostly made up of omega-3 fatty acids.
Previously: Amarin reports positive results from REDUCE-IT study; shares up 307% premarket (Sept. 24)
If they are worth $50.00 in a buyout with a single drug just imagine what we will be worth with multiple blockbusters! Just goes to show how undervalued we are at this time. Go IPIX!!!
Citi sees another 5x upside in Amarin
Sep. 24, 2018 11:53 AM ET|By: Stephen Alpher, SA News Editor
Amarin (NASDAQ:AMRN) has skyrocketed more than 200% to $10.15 today after its fish oil capsule showed big benefits in a trial of more than 8K patients with elevated risk of heart issues.
Assuming the expanded REDUCE-IT label is granted, Citi sees peak sales of a whopping $2.7B. That assumes only about 2M of the 50B-70B eligible patients are treated. The team there sees upside to $50 per share, with Amarin being a strong acquisition target. Source: Notable Calls
Also on the move on the news is Acasti Pharma (ACST +26.9%), whose heart pill candidate CaPre is mostly made up of omega-3 fatty acids.
Previously: Amarin reports positive results from REDUCE-IT study; shares up 307% premarket (Sept. 24)
If they are worth $50.00 in a buyout with a single drug just imagine what we will be worth with multiple blockbusters! Just goes to show how undervalued we are at this time. Go IPIX!!!
(2)
(0)